MFWJX
Price
$16.84
Change
+$0.11 (+0.66%)
Updated
Apr 24 closing price
Net Assets
1.2B
RIRCX
Price
$71.48
Change
+$0.74 (+1.05%)
Updated
Apr 24 closing price
Net Assets
107.13B
Ad is loading...

MFWJX vs RIRCX

Header iconMFWJX vs RIRCX Comparison
Open Charts MFWJX vs RIRCXBanner chart's image
MFS Global Total Return R4
Price$16.84
Change+$0.11 (+0.66%)
VolumeN/A
Net Assets1.2B
American Funds Capital Income Bldr R3
Price$71.48
Change+$0.74 (+1.05%)
VolumeN/A
Net Assets107.13B
MFWJX vs RIRCX Comparison Chart
Loading...
View a ticker or compare two or three
VS
MFWJX vs. RIRCX commentary
Apr 25, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MFWJX is a StrongBuy and RIRCX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
RIRCX has more cash in the bank: 107B vs. MFWJX (1.2B). RIRCX pays higher dividends than MFWJX: RIRCX (2.84) vs MFWJX (2.20). MFWJX was incepted earlier than RIRCX: MFWJX (20 years) vs RIRCX (23 years). MFWJX (0.96) is less costly to investors than RIRCX (0.91). MFWJX has a lower initial minimum investment than RIRCX: MFWJX (0) vs RIRCX (250). RIRCX annual gain was more profitable for investors over the last year : 10.36 vs. MFWJX (-0.09). RIRCX return over 5 years is better than : 45.14 vs. MFWJX (9.88).
MFWJXRIRCXMFWJX / RIRCX
Total Expense Ratio0.860.9195%
Annual Report Gross Expense Ratio0.960.91105%
Fund Existence20 years23 years-
Gain YTD2.7904.17567%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets1.2B107B1%
Annual Yield % from dividends2.202.8477%
Returns for 1 year-0.0910.36-1%
Returns for 3 years2.7314.6319%
Returns for 5 years9.8845.1422%
Returns for 10 years14.7532.5145%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
XNET4.080.21
+5.43%
Xunlei Limited
DRS36.710.77
+2.14%
Leonardo DRS
COUR7.700.10
+1.32%
Coursera
EBF18.060.04
+0.22%
Ennis
SLRX0.72N/A
+0.07%
Salarius Pharmaceuticals Inc.